Extended-Release ADHD Drug

Another extended-release amphetamine-dextroamphetamine combination medication has receivedapproval for the treatment of attention-deficit/hyperactivity disorder (ADHD). Marketed as Mydayis, the drug is indicated for teens and adults. Children aged 12 years or younger should not take the drug.
Source: JAMA - Category: General Medicine Source Type: research